House Lawmakers Blast FDA For $1B User Fee Surplus

Law360, Washington (June 18, 2013, 2:21 PM EDT) -- A U.S. House of Representatives committee on Thursday bashed the U.S. Food and Drug Administration for failing to utilize more than $1 billion of industry user fees as well as the "unpredictable nature and pace" of its rulemaking process, saying it planned to hold the agency more accountable for its funds and industry communication.

According to a House Appropriations Committee draft report dated Thursday, FDA has accrued more than $1 billion in industry user fees in the first six months of the fiscal year that it...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.